1.220USDMkt Cap: 622350 USDP/E: —Last update: 2026-05-21
Aditxt, Inc. focuses on discovery and development of biopharmaceutical products. The company develops AditxtScore and FlowSpot that enable individuals to understand, manage, and monitor their immune profiles in order to …
Industry Peers
Biotechnologyloading…
Indicators:|
Key Statistics
Company
Market Cap622.35K USD
Enterprise Value-1.81M USD
Revenue (TTM)3.19K USD
Gross Profit268 USD
Net Income (TTM)-41.71M USD
Revenue/Share0.0860 USD
Last Price1.220 USD
Fiscal Year EndDec 2025
MR QuarterDec 2025
Employees26
CountryUS
SectorHealthcare
IndustryBiotechnology
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)-0.11
PEG—
EV/EBITDA0.09
EV/Revenue-565.63
P/S194.79
P/B0.09
EPS (TTM)-2828.18
EPS (Forward)-11.29
52W Range
1.12032% of range1.433
52W High1.433 USD
52W Low1.120 USD
Profitability
Gross Margin8.39%
Oper. Margin-1098725.60%
EBITDA Margin0.00%
Profit Margin-1305608.79%
ROE-743.61%
ROA-252.56%
Growth
Revenue Growth-86.60%
Earnings Growth—
Cash Flow & Leverage
Operating CF-25.69M USD
CapEx (TTM)13.74K USD
FCF Margin-566450.33%
FCF Yield-2908.02%
Net Debt-192.07K USD
Net Debt/EBITDA0.01
Balance Sheet
Debt/Equity0.54
Current Ratio0.31
Quick Ratio0.26
Book Value/Sh13.63 USD
Cash/Share95.48 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Splits
Last Split1:27
Split DateMay 18, 2026
Analyst Consensus
Rating—
Target (Mean)—
Target Range—
# Analysts—
Ownership
Shares Out.510.12K
Float32.77K
Insiders0.09%
Institutions0.22%
Short Interest
Short Ratio0.1d
Short % Float27.04%
Short % Out.27.04%
Shares Short9.06K
Short (prev mo.)5.51K
Technical
SMA 5015.46 (-92.1%)
SMA 2006210.57 (-100.0%)
Beta-17.50
S&P 52W Chg28.31%
Avg Vol (30d)305.27K
Avg Vol (10d)373.05K
Technical Indicators
RSI (14)—
MACD—
MACD Signal—
MACD Hist.—
BB Upper—
BB Middle—
BB Lower—
BB Width—
ATR (14)—
Vol Ratio (20d)—